Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Paul Senior who wrote (40333)	11/30/2010 1:24:19 PM
From: E_K_S	Read Replies (3) \| Respond to of 78717

Good point Paul for ABT vs LLY. Covidien plc. Ordinary Shares ((NYSE: COV ) I went for COV for a medical devise company. The COV dividend is much smaller than what ABT pays. I do want to add some other pharmaceutical companies. My favorite is Merck & Co. Inc. (MRK). I would like to add more at any price below $30.00/share. My last buys in MRK were $27.00 and $29.00 in 4th Qtr 2008 and 2nd Qtr 2009 respectively. finance.yahoo.com If MRK ever gets back down below $30.00/share, their dividend should yield over 5%. EKS FWIW - ULTR may see $7.00/share today. It's been a long hold for me but I am going to like the road back to $15.00/share especially after loading up last year in the $2.50/share area. Been looking to add to Fibria Celulose SA (FBR) (the re-emerged ARACRUZ CELULSE ADR NEWF (M) (ARA)- Brazilian Wood fiber producer). These two companies (FBR & ULTR) should be good South America emerging market plays. finance.yahoo.com